Total Holdings
90
As of Oct 4, 2026
Global X Aging Population ETF
AGNGNASDAQGlobal XEquity
$38.63Today:- (-)1Y +13.60%
As of Oct 23, 2026 close
- Assets (AUM)
- $87.88M
- Expense ratio
- 0.50%
- Dividend yield
- 0.85%
- Holdings
- 90
- 52-week range
- $33.63$39.48
- Volume (live)
- -
- Avg. volume (3M)
- 10.04K
AGNG ETF Holdings: Global X Aging Population ETF
Every listed position with its portfolio weight, plus sector breakdown and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Top 10 Holdings
33.8%
Share of fund assets
Assets (AUM)
$87.88M
Total fund assets
Expense Ratio
0.50%
Annual management fee
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 54 of 90 AGNG Holdings by Portfolio Weight
Holdings as of Oct 4, 2026. Ticker, name, asset type and portfolio weight for each position. Fund disclosures available to us list the largest 54 positions.
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | AbbVie Inc. | Stock | 3.74% |
| 2 |  | Eli Lilly and Company | Stock | 3.67% |
| 3 |  | Merck & Co., Inc | Stock | 3.57% |
| 4 |  | Amgen Inc. | Stock | 3.42% |
| 5 |  | Welltower Inc | Stock | 3.35% |
| 6 |  | Johnson & Johnson | Stock | 3.32% |
| 7 |  | Edwards Lifesciences Corporation | Stock | 3.25% |
| 8 | SWX:RO | Roche Holding AG | Stock | 3.25% |
| 9 |  | Bristol-Myers Squibb Company | Stock | 3.11% |
| 10 |  | Regeneron Pharmaceuticals, Inc | Stock | 3.07% |
| 11 | LSE:0QIU | Novo Nordisk A/S Class B | Stock | 3.06% |
| 12 | CPH:NOVO.B | Novo Nordisk A/S | Stock | 3.05% |
| 13 |  | Ventas, Inc | Stock | 3.03% |
| 14 |  | Medtronic plc | Stock | 2.98% |
| 15 |  | BeOne Medicines AG | Stock | 2.72% |
| 16 | BGNE | BeiGene, Ltd | Stock | 2.68% |
| 17 | SWX:SDZ | Sandoz Group AG | Stock | 2.55% |
| 18 |  | Stryker Corporation | Stock | 2.45% |
| 19 | LSE:AZN | AstraZeneca PLC | Stock | 2.38% |
| 20 |  | AstraZeneca PLC | Stock | 2.31% |
| 21 |  | DexCom, Inc | Stock | 2.28% |
| 22 | KRX:068270 | Celltrion, Inc. | Stock | 2.27% |
| 23 | EBR:UCB | UCB SA | Stock | 2.25% |
| 24 | TSE:4519 | Chugai Pharmaceutical Co. Ltd. | Stock | 2.23% |
| 25 | SWX:ALC | Alcon Inc. | Stock | 2.20% |
| 26 |  | Boston Scientific Corporation | Stock | 2.16% |
| 27 | KO:068270 | Celltrion Inc | Stock | 2.14% |
| 28 | TYO:4519 | Chugai Pharmaceutical Co., Ltd. | Stock | 2.10% |
| 29 | HKG:3692 | Hansoh Pharmaceutical Group Company Limited | Stock | 1.82% |
| 30 | TSE:4503 | Astellas Pharma Inc. | Stock | 1.82% |
| 31 | TYO:4503 | Astellas Pharma Inc. | Stock | 1.79% |
| 32 |  | Incyte Corporation | Stock | 1.68% |
| 33 | TSE:4543 | Terumo Corp. | Stock | 1.43% |
| 34 |  | United Therapeutics Corporation | Stock | 1.40% |
| 35 | SWX:STMN | Straumann Holding AG | Stock | 1.26% |
| 36 |  | Zimmer Biomet Holdings, Inc | Stock | 1.19% |
| 37 | SWX:SOON | Sonova H Ag | Stock | 1.17% |
| 38 |  | Exelixis, Inc | Stock | 1.02% |
| 39 |  | Neurocrine Biosciences, Inc | Stock | 0.95% |
| 40 |  | Omega Healthcare Investors, Inc | Stock | 0.93% |
| 41 |  | Halozyme Therapeutics, Inc | Stock | 0.92% |
| 42 | ETR:FME | Fresenius Medical Care AG & Co. KGaA | Stock | 0.89% |
| 43 |  | DaVita Inc | Stock | 0.79% |
| 44 | LSE:SN | Smith & Nephew PLC | Stock | 0.77% |
| 45 |  | The Ensign Group, Inc | Stock | 0.68% |
| 46 |  | Insulet Corporation | Stock | 0.65% |
| 47 |  | Glaukos Corporation | Stock | 0.61% |
| 48 | ASX:COH | Cochlear Ltd | Stock | 0.44% |
| 49 |  | NovoCure Limited | Stock | 0.44% |
| 50 |  | Integer Holdings Corporation | Stock | 0.43% |
| 51 | EBR:AED | Aedifica | Stock | 0.42% |
| 52 | SWX:YPSN | Ypsomed Holding AG | Stock | 0.40% |
| 53 |  | CG Oncology, Inc. Common stock | Stock | 0.39% |
| 54 |  | MannKind Corp | Stock | 0.38% |
Source: Fund holdings disclosures. Data as of Oct 4, 2026. Data sources and methodology
Frequently Asked Questions About Global X Aging Population ETF Holdings
What are the top holdings in AGNG?
As of Oct 4, 2026, Global X Aging Population ETF (AGNG) holds 90 securities. The largest are AbbVie Inc. (3.74%), Eli Lilly and Company (3.67%), Merck & Co., Inc (3.57%). The holdings table lists each position by portfolio weight with its ticker, name and asset type.
How concentrated is AGNG's portfolio?
As of Oct 4, 2026, the 10 largest positions make up 33.8% of AGNG's assets. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly.
What is AGNG's sector allocation?
The Sector Allocation chart shows how AGNG distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does AGNG invest in?
AGNG's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is AGNG ETF?
AGNG's diversification can be assessed by reviewing its 90 holdings (as of Oct 4, 2026), sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.